Lansforsakringar Fondforvaltning’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.19M Buy
91,840
+86,382
+1,583% +$5.76M 0.03% 410
2026
Q1
$343K Buy
5,458
+1,340
+33% +$93.3K ﹤0.01% 537
2025
Q4
$273K Sell
4,118
-36,180
-90% -$2.34M ﹤0.01% 548
2025
Q3
$2.71M Sell
40,298
-200
-0.5% -$15.8K 0.01% 467
2025
Q2
$3.54M Sell
40,498
-3,717
-8% -$291K 0.02% 444
2025
Q1
$3.02M Sell
44,215
-1,195
-3% -$97.5K 0.02% 462
2024
Q4
$3.53M Buy
+45,410
New +$3.36M 0.02% 455

Other funds holding DXCM

Lansforsakringar Fondforvaltning's DXCM Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning increased its DexCom (DXCM) stake by 1,583% in Q2 2026, buying an estimated $5.76M and bringing the position to 91,840 shares worth $6.19M. The position accounts for 0.03% of the portfolio, ranked #410.

Lansforsakringar Fondforvaltning first reported a position in DXCM in Q4 2024 and has held it in 7 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 91,840 shares of DexCom worth $6.19M as of Q2 2026.
  • Lansforsakringar Fondforvaltning bought 86,382 DexCom shares in Q2 2026, an estimated $5.76M.
  • DexCom made up 0.03% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #410 holding.
  • Lansforsakringar Fondforvaltning first reported a position in DexCom in Q4 2024 and has held it in 7 quarters since.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.